Show simple item record

dc.contributor.authorPancewicz, Joanna
dc.contributor.authorNicot, Christophe
dc.date.accessioned2015-05-26T21:18:25Z
dc.date.available2015-05-26T21:18:25Z
dc.date.issued2011-11-30en_US
dc.identifier.urihttp://hdl.handle.net/2271/1320en_US
dc.description.abstractAbstract The Notch signaling pathway is highly conserved from Drosophila to humans and plays an important role in the regulation of cellular proliferation, differentiation and apoptosis. Constitutive activation of Notch signaling has been shown to result in excessive cellular proliferation and a wide range of malignancies, including leukemia, glioblastoma and lung and breast cancers. Notch can also act as a tumor suppressor, and its inactivation has been associated with an increased risk of spontaneous squamous cell carcinoma. This minireview focuses on recent advances related to the mechanisms and roles of activated Notch1, Notch2, Notch3 and Notch4 signaling in human lymphocytic leukemia, myeloid leukemia and B cell lymphoma, as well as their significance, and recent advances in Notch-targeted therapies.
dc.titleCurrent views on the role of Notch signaling and the pathogenesis of human leukemia
dc.typeArticleen_US
dc.identifier.doi10.1186/1471-2407-11-502en_US
dc.date.updated2012-01-16T16:10:42Z
dc.description.versionPeer Reviewed
dc.rights.holderPancewicz et al.; licensee BioMed Central Ltd.
dc.rights.accessrightsopenAccessen_US


Files in this item

Thumbnail
Thumbnail

This item appears in the following Collection(s)

Show simple item record